http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101946779-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
| filingDate | 2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101946779-B1 |
| titleOfInvention | Mycoplasma-neutralizing epitope and antibodies against the same |
| abstract | The present invention relates to a mycoplasma neutralizing epitope and an antibody therefor, and can effectively inhibit mycoplasma infection to cells by treating an antibody specifically recognizing the 226th to 246th amino acids of the mycoplasma enzymolysis p37 protein As a result, the present invention can fundamentally block mycoplasma contamination that accompanies cell culture. |
| priorityDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 353.